Alnylam PharmaceuticalsALNY 
$243.250.41%24h
0.41%24h
Global rank568
Market cap$30.38B
Change 7d-3.61%
YTD Performance-
SP500 benchmark
P/E-69.11
P/S16.62
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Market capitalization of Alnylam Pharmaceuticals (ALNY)
As of January 2025, Alnylam Pharmaceuticals has a market cap of $30.38B. This makes Alnylam Pharmaceuticals the world's 568th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Alnylam Pharmaceuticals from 2004 to 2024
-
Value:-
Market cap history of Alnylam Pharmaceuticals from 2004 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $18.39B | -23.07% |
| 2023 | $23.91B | -19.46% |
| 2022 | $29.68B | 40.14% |
| 2021 | $21.18B | 30.48% |
| 2020 | $16.23B | 12.85% |
| 2019 | $14.39B | 57.96% |
| 2018 | $9.11B | -42.61% |
| 2017 | $15.87B | 239.34% |
| 2016 | $4.68B | -60.23% |
| 2015 | $11.76B | -2.95% |
| 2014 | $12.12B | 50.86% |
| 2013 | $8.03B | 252.33% |
| 2012 | $2.28B | 123.93% |
| 2011 | $1.02B | -17.34% |
| 2010 | $1.23B | -44.04% |
| 2009 | $2.20B | -28.75% |
| 2008 | $3.09B | -14.96% |
| 2007 | $3.63B | 35.89% |
| 2006 | $2.67B | 60.66% |
| 2005 | $1.66B | 78.31% |
| 2004 | $933.05M | - |
ALNY Market Cap Today is $30.38B 0.41% - 7 Jan 2025
View largest stocks by market cap 
